These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1699613)

  • 21. The effect of hypoxia on monoamine synthesis, levels and metabolism in rat brain.
    Davis JN; Carlsson A
    J Neurochem; 1973 Oct; 21(4):783-90. PubMed ID: 4148239
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of triethyltin chloride on the central aminergic neurotransmitters and their metabolites: relationship with pathophysiology of aging.
    Bentue-Ferrer D; Reymann JM; Van den Driessche J; Allain H; Bagot H
    Exp Aging Res; 1985; 11(3-4):137-41. PubMed ID: 2416571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a new, short-acting and specific inhibitor of type A monoamine oxidase.
    Waldmeier PC; Baumann PA; Delini-Stula A; Bernasconi R; Sigg K; Buech O; Felner AE
    Mod Probl Pharmacopsychiatry; 1983; 19():31-52. PubMed ID: 6191211
    [No Abstract]   [Full Text] [Related]  

  • 24. Lack of neurochemical evidence for neurotoxic effects of repeated cocaine administration in rats on brain monoamine neurons.
    Yeh SY; De Souza EB
    Drug Alcohol Depend; 1991 Jan; 27(1):51-61. PubMed ID: 1709403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversibility of the interaction of CGP 11305 A with MAO A in vivo.
    Waldmeier PC; Feldtrauer JJ; Stoecklin K; Paul E
    Eur J Pharmacol; 1983 Oct; 94(1-2):101-8. PubMed ID: 6197309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
    Sloley BD; Urichuk LJ; Morley P; Durkin J; Shan JJ; Pang PK; Coutts RT
    J Pharm Pharmacol; 2000 Apr; 52(4):451-9. PubMed ID: 10813558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Monoamines (3): postmortem studies on the human brain in a suicide group].
    Gottfries CG; Winblad B
    Lakartidningen; 1978 Feb; 75(8):663-5. PubMed ID: 634000
    [No Abstract]   [Full Text] [Related]  

  • 28. Monoamine and metabolite levels in CNS regions of the P line of alcohol-preferring rats after acute and chronic ethanol treatment.
    Murphy JM; McBride WJ; Lumeng L; Li TK
    Pharmacol Biochem Behav; 1983 Nov; 19(5):849-56. PubMed ID: 6196794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic characteristics of dopamine, norepinephrine and serotonin metabolism in axonal endings of the rat hypothalamus and striatum during hypoxia: a study using HPLC with electrochemical detection.
    Saligaut C; Chretien P; Daoust M; Moore N; Boismare F
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):343-9. PubMed ID: 2426539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-induced changes in the efflux of dopamine and serotonin metabolites from the brains of freely moving rats.
    Moore KE
    Ann N Y Acad Sci; 1986; 473():303-20. PubMed ID: 2432822
    [No Abstract]   [Full Text] [Related]  

  • 31. Temporal profile of aminergic neurotransmitter release in striatal dialysates in rats with post-ischemic seizures.
    Bentué-Ferrer D; Bellissant E; Decombe R; Allain H
    Exp Brain Res; 1994; 97(3):437-43. PubMed ID: 7514544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain.
    Fattaccini CM; Gozlan H; Hamon M
    Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of neurotransmitter metabolism by dihydropyridine calcium channel ligands in mouse brain.
    Bolger GT; Lesieur P; Basile AS; Skolnick P
    Brain Res; 1988 Jan; 438(1-2):101-7. PubMed ID: 2449929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of acute and chronic cholinesterase inhibition on biogenic amines in rat brain.
    Soininen H; Unni L; Shillcutt S
    Neurochem Res; 1990 Dec; 15(12):1185-90. PubMed ID: 1711162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of repeated dietary exposure of aflatoxin B1 on brain biogenic amines and metabolites in the rat.
    Coulombe RA; Sharma RP
    Toxicol Appl Pharmacol; 1985 Sep; 80(3):496-501. PubMed ID: 2412309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoamine levels and monoamine oxidase activity in different regions of rat brain as a function of age.
    Bhaskaran D; Radha E
    Mech Ageing Dev; 1983 Oct; 23(2):151-60. PubMed ID: 6140331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of type A and B monoamine oxidase on the formation of 3,4-dihydroxyphenylacetic acid (DOPAC) in tissues from the brain of the rat.
    Garrett MC; Soares-da-Silva P
    Neuropharmacology; 1990 Oct; 29(10):875-9. PubMed ID: 2123970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of butorphanol and its metabolites on the levels of monoamines and their metabolites in the rat brain.
    Niwa M; Nose T; Nozaki M; Tsurumi K; Fujimura H
    Jpn J Pharmacol; 1985 Dec; 39(4):515-28. PubMed ID: 2419614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.